SCHEMBL6687382

SCHEMBL6687382

CC(CCNC(=O)O)CC(=O)N(CC(=O)CNS(=O)(=O)c1ccc2oc3ccccc3c2c1)Cc1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 7/20 0.43
▸ MMP13 P45452 6/20 0.43
▸ HTT P42858 3/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KEAP1 Q14145 1/20 0.37
▸ GAA P10253 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6687741 0.87 MMP12 (0.40) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL5934949 0.81 MMP12 (0.44) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL6681062 0.79 MMP12 (0.43) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL7380975 0.79 MMP12 (0.44) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL6687739 0.77 MMP12 (0.42) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL6683187 0.76 MMP12 (0.40) MMP12MMP13
SCHEMBL5934913 0.75 MMP12 (0.47) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL6681323 0.74 HTT (0.41) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL7374325 0.73 MMP12 (0.47) MMP12MMP13HTTCYP1A2CYP2C19
SCHEMBL6685713 0.70 MMP12 (0.43) MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058238-A1 USE OF CATHEPSIN K INHIBITORS FOR THE TREATMENT OF GLAUCOMA ALCON, INC. (CH) 2004-07-15 — — WO claimed
EP-0934291-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1999-08-11 — — EP claimed
EP-0934291-A4 — SMITHKLINE BEECHAM CORP (US) 1999-08-11 — — EP claimed
WO-1997016433-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1997-05-09 — — WO claimed
EP-0934291-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1999-08-11 — — EP disclosed
EP-0934291-A4 — SMITHKLINE BEECHAM CORP (US) 1999-08-11 — — EP disclosed
WO-1997016433-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1997-05-09 — — WO disclosed
Send feedback